3WHO.Laboratory diagnosis of measles infection and monitoring of measles immunization:Memorandum from a WHO meeting[J].Bull WHO,1994,72:207-211.
4Ramsay M,Brugha R,Brown D.Surveillance of measles in England and Wales:implications of a national saliva testing program[J].Bull WHO,1997,75:515-521.
5Blackbum N,Schoub B,Counell K.Reliability of the clinical surveillance criteria for measles diagnosis[J].Bull WHO,2000,78(6):861.
6Bdour S,Batayneh N.Present anti measles immunity in Jordan[J].Vaccine,2001,19(28 29):3865 3869.
7WHO.measles progress towards global control and regional elimination,1998-1999[J].WER,1999,74:429-434.
8Sniadack DH,Moscoso B,Aguilar R,et al.Measles epidemiology and outbreak response immunization in arural community in Peru[J].BullWHO,1999,77(7):545-552.
9Miller M, Williams W W, Redd S C. Measles among adults, United States,1985 - 1995[ J]. Am J Prey Med,1999,17(2) :114 - 119.
10Pena Rey Lorenzo I, Santa Olalla P, Amela Heras C. Measles in Spain : its move into the agult population [ J ]. Aten Primaria, 2004,33 ( 4 ) : 200 - 202.
